Contemporary Pharmacotherapeutic Approach in Pulmonary Arterial Hypertension

Authors

Jalil Ahari, School of Medicine and Health Sciences
Akshay Bhatnagar, School of Medicine and Health Sciences
Anna Johnson, School of Medicine and Health Sciences
Mardi Gomberg-Maitland, School of Medicine and Health Sciences

Document Type

Journal Article

Publication Date

3-1-2021

Journal

Clinics in Chest Medicine

Volume

42

Issue

1

DOI

10.1016/j.ccm.2020.10.002

Keywords

Clinical trials; Endothelial antagonist; Guanylate cyclase stimulator; Pharmacologic treatment approach; Phosphodiesterase inhibitor; Prostacyclin; Prostanoid

Abstract

© 2020 Elsevier Inc. Since the 1973 World Symposium on Pulmonary Hypertension, advancements in the understanding of pathophysiology and pathobiology have led to a myriad of pharmacotherapies for the disease. This article journeys through the development of therapeutic approaches for pulmonary arterial hypertension.

APA Citation

Ahari, J., Bhatnagar, A., Johnson, A., & Gomberg-Maitland, M. (2021). Contemporary Pharmacotherapeutic Approach in Pulmonary Arterial Hypertension. Clinics in Chest Medicine, 42 (1). http://dx.doi.org/10.1016/j.ccm.2020.10.002